Zyban for smoking cessation in a general practice setting: The response to an invitation to make a quit attempt

Addiction Biology

Volumn 9, Issue 3-4, 2004, Pages 227-232

  Johnstone, Elaine ^a,b   Hey, Kate ^a   Drury, Mark ^a   Roberts, Sarah ^a   Welch, Sarah ^a   Walton, Robert ^a   Murphy, Mike ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; COTININE; DOPAMINE 2 RECEPTOR; NICOTINE;

ABSTINENCE; ADULT; ARTICLE; CIGARETTE SMOKING; DOPAMINERGIC SYSTEM; FEMALE; GENE FREQUENCY; GENERAL PRACTICE; GENOTYPE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALIVA ANALYSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING CESSATION; SOCIOECONOMICS; TOBACCO DEPENDENCE; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; BUPROPION; DOPAMINE UPTAKE INHIBITORS; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RETREATMENT; SEX FACTORS; SMOKING CESSATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 8544283041     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210412331312421     Document Type: Article

References (14)

1. Jarvis M, Wardle J. Social patterning of individual health behaviours: the case of cigarette smoking. In: Marmot M, Wilkinson R, editors. Social determinants of health. Oxford: Oxford University Press; 1999.
2. Tonnesen P, Paoletti P, Gustavsson G, Russell MA, Saracci R, Gulsvik A, Rijcken B, Sawe U. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J 1999;13(2):238-246.
3. Tonnesen P, Tonstad S, Hjalmarson A, Lebargy F, Van Spiegel PI, Hider A, Sweet R, Townsend J. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J Intern Med 2003;254(2): 184-192.
4. Munafo' MR, Bradburn M, Bowes L, David SP. Are there sex differences in transdermal replacement therapy patch efficacy? A meta-analysis. Nicotine Tob Res 2004;in press.
5. Swan GE, Jack LM, Curry S, Chorost M, Javitz H, McAfee T, Dacey S. Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome. Nicotine Tob Res 2003;5(6):911-921.
6. Johnstone EC, Yudkin PL, Hey K, Roberts SJ, Welch SJ, Murphy MFG, Griffiths SE, Walton RT. Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics 2004;14(2):83-90.
7. Lerman C, Shields PG, Wileyto EP, Audrain J, Pinto A, Hawk L, Krishnan S, Niaura R, Epstein L. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics 2002;12(8): 627-634.
8. Munafo' MR, Clark TG, Johnstone EC, Murphy MFG, Walton R. The genetic basis for smoking behaviour: A systematic review and meta-analysis. Nicotine Tob Res 2004;6(4):1-15.
9. Yudkin P, Munafo M, Hey K, Roberts S, Welch S, Johnstone E, Murphy M, Griffiths S, Walton R. Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial. BMJ 2004;328(7446):989-990.
10. Yudkin PL, Jones L, Lancaster T, Fowler GH. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. Br J Gen Pract 1996;46(404):145-148.
11. Yudkin P, Hey K, Roberts S, Welch S, Murphy M, Walton R. Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch. BMJ 2003;327(7405):28-29.
12. Holmes S, Zwar N, Jimenez-Ruiz CA, Ryan PJ, Browning D, Bergmann L, Johnston JA. Bupropion as an aid to smoking cessation: a review of real-life effectiveness. Int J Clin Pract 2004;58(3): 285-291.
13. Collins BN, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Kaufmann V, Pinto A, Hawk L, Niaura R, Epstein LH, Lerman C. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine Tob Res 2004;6(1):27-37.
14. Swan GE, McAfee T, Curry SJ, Jack LM, Javitz H, Dacey S, Bergman K. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med 2003;163(19):2337-2344.